Onconetix, Inc. (ONCO) vs VivoSim Labs, Inc. (VIVS)
- Onconetix, Inc. ONCO 0.48 −12.73%
- VivoSim Labs, Inc. VIVS 0.16 −5.88%
Onconetix, Inc. and VivoSim Labs, Inc. are both Biotechnology companies. Onconetix, Inc. and VivoSim Labs, Inc. are of similar size ($2.9M and $2.8M). VivoSim Labs, Inc. has negative trailing earnings, so its P/E is not meaningful; Onconetix, Inc. trades at 0.0×. VivoSim Labs, Inc. grew revenue faster over the last twelve months: −21.1% against −51.3%. Onconetix, Inc. has the higher net margin (−1,578.6% vs −11,016.1%) and the lower return on invested capital (−135.4% vs 0.00%). Across the 16 metrics below, Onconetix, Inc. leads on 9 and VivoSim Labs, Inc. on 7.
Valuation
Profitability
| Metric | ONCO | VIVS | Biotechnology median |
|---|---|---|---|
| Gross margin | 80.38% | 100.00% | 65.16% |
| Operating margin | (2,524.73%) | (10,116.96%) | 0.00% |
| Net margin | (1,578.60%) | (11,016.07%) | 0.00% |
| Free cash flow margin | (1,595.90%) | (1,014.29%) | 0.00% |
| Return on equity | (105.23%) | (343.10%) | (56.36%) |
| Return on assets | (57.37%) | (155.93%) | (48.04%) |
| Return on invested capital | (135.42%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack